Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
2.020
+0.390 (23.93%)
At close: Dec 16, 2025, 4:00 PM EST
2.050
+0.030 (1.47%)
After-hours: Dec 16, 2025, 7:59 PM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $187.31 million as of December 16, 2025. Its market cap has decreased by -35.85% in one year.
Market Cap
187.31M
Enterprise Value
36.57M
1-Year Change
-35.85%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $187.31M, an increase of 12.16%. That is a compound annual growth rate of 2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 187.30M | -34.03% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |